Prostate cancer is the second most common cause of male cancer deaths in the United States. However, the full range of prostate cancer genomic alterations is incompletely characterized. Here we present the complete sequence of seven primary human prostate cancers and their paired normal counterparts. ...
36.8 prostate cancer deaths in every 100,000 non-Hispanic black males 17.8 deaths per 100,000 non-Hispanic white males 15.4 deaths per 100,000 Hispanic males Experts aren't sure exactly what causes these differences. The causes likely involve a mix of social and biological factors, including: ...
Prostate Cancer Deaths Fall Four Times Faster in the US
Prostate cancer remains a leading cause of cancer incidence and mortality worldwide, with 1.6 million new cases and 366,000 deaths annually1. Although prostate-specific antigen (PSA) screening was associated with a 51% reduction in PrCa mortality in the United States between 1993 and 20142, the ...
For men who reported a diagnosis of prostate cancer (or next of kin for decedents), we requested permission to obtain medical records and pathological reports to confirm the diagnosis and obtain further details. Most deaths in the cohort were ascertained through reports from family members and ...
(PCa) and 375,000 deaths were recorded in 2020. Currently, this disease is recognized as the second most common cancer and ranks fifth in causes of death among men worldwide[2,3]. Therefore, accurate and early diagnosis of this disease is vital. Prostate-specific antigen (PSA) is aserine...
Prostate cancer is the most commonly diagnosed malignancy and the third leading cause of cancer deaths. GWAS have identified variants associated with prost... M Stentenbach,JA Ermer,DL Rudler,... - 《Embo Molecular Medicine》 被引量: 0发表: 2023年 Prostate Cancer Genetics Prostate cancer ( PC...
Roles of the Na+/H+ Exchanger Isoform 1 and Urokinase in Prostate Cancer Cell Migration and Invasion Prostate cancer is a leading cause of cancer-associated deaths in men over 60 years of age. Most patients ...
Prostate cancer ranks as the second most prevalent malignant tumor among men worldwide, with over 1.41 million new cases and 370,000 deaths annually, posing a significant threat to male health1. In recent years, Multiparametric Magnetic Resonance Imaging (mpMRI), owing to its rich imaging paramet...
ArticleOpen access02 September 2023 The potential of CAR T cell therapy for prostate cancer Article08 July 2021 Introduction Metastatic prostate cancer represents an incurable disease responsible for over 33,000 deaths per year in the United States1. Prostate cancer is critically reliant on androgen ...